-
平臺(tái)編號(hào)：bio-50933
-
國(guó)際編號(hào)：ATCC VR-2269
-
拉丁屬名： AUTOGRAPHA CALIFORNICA, RECOMBINANT BACULOVIRUSStrain: Ac CC2
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
苜蓿銀紋夜蛾，重組baculovirusstrain：AC CC2
ATCC? Number:VR-2269?
Classification: Baculovirus
Agent: Nuclear polyhedrosis virus, Autographa californica
Strain: AcCC2
Original Source: Nuclear polyhedrosis virus, Autographa californica recombinant with human alpha-galactosidase A precursor gene
Depositors: DH Calhoun
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : Sf9 cells (ATCCCRL-1711) many Lepidopterm insect cell lines
Effect : Yes, in vitro effects: Expanded nuclei in enlarged cells (25 - 50% increase in diameter). Lysis at late times p.i
Store at : -70C
Comments : AcCC1 and AcCC2 are plague purified occlusion negative recombinant baculovirus resulting from the co-transfection of Sf-9 cells with pCC4 (transfer vector) and AcMNPV DNA.
References : 21036: Calhoun DH, Coppola G. Recombinant alpha-galactosidase A therapy for Fabry disease. US Patent 5,179,023 dated Jan 12 1993
